Sarah R. Mudd, Ph.D. - Publications

Affiliations: 
2010 University of Wisconsin, Madison, Madison, WI 
Area:
Radiology

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Mudd S, Voorbach MJ, Cheng D, Cheng M, Guo J, Gao W, Buchanan FG, Tse C, Wilsbacher JL. Utilization of 18F-fluorodeoxyglucose - positron emission tomography (FDG-PET) to understand the mechanism of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors in vivo. The Journal of Pharmacology and Experimental Therapeutics. PMID 31562200 DOI: 10.1124/Jpet.119.259135  0.427
2013 Ji S, Zhou Y, Voorbach MJ, Shao G, Zhang Y, Fox GB, Albert DH, Luo Y, Liu S, Mudd SR. Monitoring tumor response to linifanib therapy with SPECT/CT using the integrin αvβ3-targeted radiotracer 99mTc-3P-RGD2. The Journal of Pharmacology and Experimental Therapeutics. 346: 251-8. PMID 23750021 DOI: 10.1124/Jpet.112.202622  0.491
2013 Phillips AC, Boghaert ER, Vaidya KS, Ansell PJ, Shalinsky DR, Zhang Y, Voorbach MJ, Mudd S, Holen KD, Humerickhouse RA, Reilly EB. Abstract A250: ABT-414: An anti-EGFR antibody-drug conjugate as a potential therapeutic for the treatment of patients with squamous cell tumors. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-A250  0.427
2012 Grudzinski JJ, Floberg JM, Mudd SR, Jeffery JJ, Peterson ET, Nomura A, Burnette RR, Tomé WA, Weichert JP, Jeraj R. Application of a whole-body pharmacokinetic model for targeted radionuclide therapy to NM404 and FLT. Physics in Medicine and Biology. 57: 1641-57. PMID 22398155 DOI: 10.1088/0031-9155/57/6/1641  0.55
2012 Mudd SR, Voorbach MJ, Reuter DR, Tapang P, Hickson JA, Refici-Buhr M, Fox GB, Albert DH, Luo Y, Day M. FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft model Cancer Chemotherapy and Pharmacology. 69: 1669-1672. PMID 22327787 DOI: 10.1007/S00280-012-1840-Z  0.44
2012 Mudd SR, Holich KD, Voorbach MJ, Cole TB, Reuter DR, Tapang P, Bukofzer G, Chakravartty A, Donawho CK, Palma JP, Fox GB, Day M, Luo Y. Pharmacodynamic evaluation of irinotecan therapy by FDG and FLT PET/CT imaging in a colorectal cancer xenograft model. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 14: 617-24. PMID 22167582 DOI: 10.1007/S11307-011-0529-8  0.374
2012 Luo F, Rustay NR, Ebert U, Hradil VP, Cole TB, Llano DA, Mudd SR, Zhang Y, Fox GB, Day M. Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease. Neurobiology of Aging. 33: 933-44. PMID 20961663 DOI: 10.1016/J.Neurobiolaging.2010.08.005  0.365
2010 Mudd SR, Trubetskoy VS, Blokhin AV, Weichert JP, Wolff JA. Hybrid PET/CT for noninvasive pharmacokinetic evaluation of dynamic PolyConjugates, a synthetic siRNA delivery system. Bioconjugate Chemistry. 21: 1183-9. PMID 20552976 DOI: 10.1021/Bc900558Z  0.505
2008 Durkee BY, Mudd SR, Roen CN, Clipson L, Newton MA, Weichert JP, Pickhardt PJ, Halberg RB. Reproducibility of tumor volume measurement at microCT colonography in living mice. Academic Radiology. 15: 334-41. PMID 18280931 DOI: 10.1016/J.Acra.2007.10.005  0.379
Show low-probability matches.